vs

Side-by-side financial comparison of RxSight, Inc. (RXST) and WIDEPOINT CORP (WYY). Click either name above to swap in a different company.

WIDEPOINT CORP is the larger business by last-quarter revenue ($42.3M vs $32.6M, roughly 1.3× RxSight, Inc.). WIDEPOINT CORP runs the higher net margin — -2.0% vs -28.1%, a 26.1% gap on every dollar of revenue. On growth, WIDEPOINT CORP posted the faster year-over-year revenue change (12.3% vs -18.9%). WIDEPOINT CORP produced more free cash flow last quarter ($-270.0K vs $-2.3M). Over the past eight quarters, WIDEPOINT CORP's revenue compounded faster (11.2% CAGR vs 5.1%).

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

WidePoint Corporation is an American company based in Fairfax, Virginia that provides technology-based products and services to the government sector and commercial markets in the United States. The company holds a patent for a digital parsing tool that allows users to access accounts through a secure repository gateway, established using asymmetric authentication employed as public key infrastructure (PKI). WidePoint provides smart card identity verification, wireless expense management, pen...

RXST vs WYY — Head-to-Head

Bigger by revenue
WYY
WYY
1.3× larger
WYY
$42.3M
$32.6M
RXST
Growing faster (revenue YoY)
WYY
WYY
+31.2% gap
WYY
12.3%
-18.9%
RXST
Higher net margin
WYY
WYY
26.1% more per $
WYY
-2.0%
-28.1%
RXST
More free cash flow
WYY
WYY
$2.0M more FCF
WYY
$-270.0K
$-2.3M
RXST
Faster 2-yr revenue CAGR
WYY
WYY
Annualised
WYY
11.2%
5.1%
RXST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RXST
RXST
WYY
WYY
Revenue
$32.6M
$42.3M
Net Profit
$-9.2M
$-849.4K
Gross Margin
77.5%
13.8%
Operating Margin
-34.8%
-1.9%
Net Margin
-28.1%
-2.0%
Revenue YoY
-18.9%
12.3%
Net Profit YoY
-54.1%
-138.3%
EPS (diluted)
$-0.22
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RXST
RXST
WYY
WYY
Q4 25
$32.6M
$42.3M
Q3 25
$30.3M
$36.1M
Q2 25
$33.6M
$37.9M
Q1 25
$37.9M
$34.2M
Q4 24
$40.2M
$37.7M
Q3 24
$35.3M
$34.6M
Q2 24
$34.9M
$36.0M
Q1 24
$29.5M
$34.2M
Net Profit
RXST
RXST
WYY
WYY
Q4 25
$-9.2M
$-849.4K
Q3 25
$-9.8M
$-559.2K
Q2 25
$-11.8M
$-618.5K
Q1 25
$-8.2M
$-724.1K
Q4 24
$-5.9M
$-356.4K
Q3 24
$-6.3M
$-425.2K
Q2 24
$-6.1M
$-499.6K
Q1 24
$-9.1M
$-653.1K
Gross Margin
RXST
RXST
WYY
WYY
Q4 25
77.5%
13.8%
Q3 25
79.9%
14.6%
Q2 25
74.9%
13.5%
Q1 25
74.8%
14.0%
Q4 24
71.6%
12.6%
Q3 24
71.4%
13.6%
Q2 24
69.5%
13.6%
Q1 24
70.1%
13.6%
Operating Margin
RXST
RXST
WYY
WYY
Q4 25
-34.8%
-1.9%
Q3 25
-40.1%
-1.3%
Q2 25
-41.6%
-1.9%
Q1 25
-28.2%
-2.4%
Q4 24
-21.5%
-0.8%
Q3 24
-26.1%
-1.3%
Q2 24
-23.9%
-1.3%
Q1 24
-36.2%
-1.9%
Net Margin
RXST
RXST
WYY
WYY
Q4 25
-28.1%
-2.0%
Q3 25
-32.4%
-1.5%
Q2 25
-35.0%
-1.6%
Q1 25
-21.6%
-2.1%
Q4 24
-14.8%
-0.9%
Q3 24
-17.9%
-1.2%
Q2 24
-17.4%
-1.4%
Q1 24
-30.8%
-1.9%
EPS (diluted)
RXST
RXST
WYY
WYY
Q4 25
$-0.22
$-0.08
Q3 25
$-0.24
$-0.06
Q2 25
$-0.29
$-0.06
Q1 25
$-0.20
$-0.08
Q4 24
$-0.14
$-0.05
Q3 24
$-0.16
$-0.04
Q2 24
$-0.16
$-0.05
Q1 24
$-0.25
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RXST
RXST
WYY
WYY
Cash + ST InvestmentsLiquidity on hand
$228.1M
$9.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.7M
$11.5M
Total Assets
$311.8M
$79.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RXST
RXST
WYY
WYY
Q4 25
$228.1M
$9.8M
Q3 25
$227.5M
$12.1M
Q2 25
$227.5M
$6.8M
Q1 25
$229.3M
$3.7M
Q4 24
$237.2M
$6.8M
Q3 24
$237.1M
Q2 24
$233.3M
Q1 24
$125.4M
Stockholders' Equity
RXST
RXST
WYY
WYY
Q4 25
$275.7M
$11.5M
Q3 25
$276.0M
$12.2M
Q2 25
$278.0M
$12.6M
Q1 25
$279.3M
$13.0M
Q4 24
$281.2M
$13.6M
Q3 24
$277.3M
$13.8M
Q2 24
$275.2M
$14.0M
Q1 24
$163.9M
$14.2M
Total Assets
RXST
RXST
WYY
WYY
Q4 25
$311.8M
$79.8M
Q3 25
$308.5M
$70.6M
Q2 25
$309.0M
$76.6M
Q1 25
$313.0M
$71.4M
Q4 24
$318.6M
$71.6M
Q3 24
$310.5M
$56.9M
Q2 24
$305.5M
$58.6M
Q1 24
$183.2M
$54.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RXST
RXST
WYY
WYY
Operating Cash FlowLast quarter
$-1.1M
$-173.5K
Free Cash FlowOCF − Capex
$-2.3M
$-270.0K
FCF MarginFCF / Revenue
-6.9%
-0.6%
Capex IntensityCapex / Revenue
3.5%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.3M
$5.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RXST
RXST
WYY
WYY
Q4 25
$-1.1M
$-173.5K
Q3 25
$-1.2M
$5.9M
Q2 25
$-4.4M
$3.2M
Q1 25
$-8.8M
$-3.2M
Q4 24
$-4.3M
$2.4M
Q3 24
$650.0K
$1.9M
Q2 24
$-4.0M
$-1.1M
Q1 24
$-9.3M
$-1.6M
Free Cash Flow
RXST
RXST
WYY
WYY
Q4 25
$-2.3M
$-270.0K
Q3 25
$-1.8M
$5.9M
Q2 25
$-5.9M
$3.1M
Q1 25
$-9.4M
$-3.3M
Q4 24
$-5.1M
$2.4M
Q3 24
$-453.0K
$1.8M
Q2 24
$-5.5M
$-1.1M
Q1 24
$-11.3M
$-1.6M
FCF Margin
RXST
RXST
WYY
WYY
Q4 25
-6.9%
-0.6%
Q3 25
-5.8%
16.4%
Q2 25
-17.6%
8.1%
Q1 25
-24.8%
-9.5%
Q4 24
-12.7%
6.4%
Q3 24
-1.3%
5.3%
Q2 24
-15.9%
-3.0%
Q1 24
-38.2%
-4.6%
Capex Intensity
RXST
RXST
WYY
WYY
Q4 25
3.5%
0.2%
Q3 25
1.9%
0.1%
Q2 25
4.6%
0.2%
Q1 25
1.5%
0.1%
Q4 24
2.1%
0.1%
Q3 24
3.1%
0.2%
Q2 24
4.4%
0.0%
Q1 24
6.7%
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

WYY
WYY

Carrier Services$26.8M63%
Managed Services$15.5M37%

Related Comparisons